The article reviews the adverse events associated with the use of HeartMate vented electric and Novacor left ventricular assist devices. The device make and type are analyzed, and the device failure rate is found to be high.
The author discusses the importance of objective information for clinical decision-making and highlights the lack of uniformity in the definitions of thromboembolic events. The article concludes that the HeartMate VE LVAD appears to have an admirable record with regard to thromboembolic event rates, even without systemic anticoagulation.
Manual:
Chat: Powered By VoiceSphere